PDCD1 and neoplasm: Moreover, BJIKT did not affect the PD-1/PD-L1 binding affinity (Figure 2G), suggesting that BJIKT exerts antitumor effects by regulating the immune response in the tumor microenvironment, rather than exerting direct cytotoxic effects on CRC cells.